Rhino Biotech Limited

OTCPK:RBRX.F Stock Report

Market Cap: US$31.0

Rhino Biotech Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Rhino Biotech's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Oil and Gas Industry Growth33.7%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2020

Recent past performance updates

No updates

Recent updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Rhino Biotech has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown

How Rhino Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:RBRX.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 200000
31 Dec 190000
31 Dec 180000
31 Dec 170000
31 Dec 160000
31 Dec 150000
31 Dec 140000

Quality Earnings: Insufficient data to determine if RBRX.F has high quality earnings.

Growing Profit Margin: Insufficient data to determine if RBRX.F's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if RBRX.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare RBRX.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if RBRX.F's earnings growth over the past year exceeded the Oil and Gas industry average.


Return on Equity

High ROE: RBRX.F has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies